MedTrace Logo

Online Radical Acceptance Intervention for Social Anxiety Disorder

NCT07325929 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-05-06

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a self-guided online Radical Acceptance program helps reduce symptoms of Social Anxiety Disorder. The study will also compare this program to an online relaxation skills program.

The main questions are:

* Does the Radical Acceptance program lower symptoms of Social Anxiety Disorder?
* Is the Radical Acceptance program more helpful than relaxation skills?

Adults with Social Anxiety Disorder will be randomly assigned to one of two online programs. They will complete a baseline learning session and six short home practice sessions over two weeks. Participants will answer surveys about their symptoms and complete brief computer tasks. Researchers will measure changes in social anxiety at several points during the study and again a few weeks and a few months later.

Conditions

  • Social Anxiety Disorder (SAD)

Interventions

BEHAVIORAL

Radical Acceptance

Online DBT-based program focusing on implementing radical acceptance in daily life and coping with socially anxious situations.

BEHAVIORAL

Relaxation Skills

Online DBT-based program teaching relaxation techniques to achieve rapid physiological down-regulation and improve emotional control.

Sponsors & Collaborators

  • University of Haifa

    lead OTHER

Principal Investigators

  • Noam Weinbach, PhD · School of Psychological Sciences, University of Haifa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-16
Primary Completion
2027-01-01
Completion
2027-04-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07325929 on ClinicalTrials.gov